Impacts of Personalized Multimodal Treatment in the Clinical Management of Androgenetic Alopecia: A Case Report

Introduction: Androgenetic alopecia (AGA) is one of the most common forms of hair loss, characterized by the progressive miniaturization of hair follicles. The condition affects both men and women and has a significant impact on patients' self-esteem and psychological well-being. The treatment of AGA remains challenging, with available therapeutic options that do not always result in satisfactory outcomes. Methodology: This case study investigated the efficacy of a multimodal treatment for AGA, combining oral therapy, at-home topical care, microinfusion of specific active ingredients, and photobiomodulation. The patient was treated with Actrisave, Saw Palmetto, Trichoxidil, and microinfusion of growth factors such as KGF and copper peptide. The treatment was carried out over a determined period, with clinical and photographic follow-up throughout the sessions. Results and Conclusion: The patient showed a significant improvement in hair density and scalp coverage. The treatment resulted in an increase in the anagen phase of the hair cycle, a reduction in the telogen phase, and greater formation of hair follicle units. Additionally, no adverse effects were reported, and the patient expressed satisfaction with the results achieved. The combination of oral, topical treatments, and microinfusion of active ingredients, along with photobiomodulation technologies, proved effective in the treatment of androgenetic alopecia, promoting hair regeneration and increased hair density. The personalized approach, which considers the specific needs of each patient, was crucial for the success of the treatment. However, further studies are needed to confirm the efficacy of these treatments on a larger scale and in the long term.